设备集采
Search documents
多地放射检查大降价,部分项目价格腰斩
2 1 Shi Ji Jing Ji Bao Dao· 2025-09-25 11:15
Core Viewpoint - The National Healthcare Security Administration (NHSA) has initiated a standardization of pricing for radiological examination services, aiming to reduce unreasonable regional disparities in pricing across provinces [1][5]. Group 1: Pricing Adjustments - Since 2025, multiple provinces have adjusted the pricing standards for common imaging examinations such as CT, MRI, and X-rays, with significant price reductions observed in high-cost procedures like PET/CT [1][2]. - In Shaanxi Province, the price for PET/CT has been reduced from over 4200 yuan to 2450 yuan, representing a nearly 40% decrease [2][6]. - The new pricing system categorizes examination items into seven major categories, including X-ray, CT, MRI, and PET/CT, with a total of 233 old items being consolidated into 26 new items [2][4]. Group 2: Digital Transformation - The new regulations eliminate the bundling of physical film with examination prices, allowing patients to access cloud imaging conveniently through mobile devices [3][6]. - If public medical institutions do not provide compliant digital imaging and cloud storage services, the examination price will be reduced by 5 yuan [3]. Group 3: Market Dynamics - The price adjustments are closely linked to centralized procurement of medical equipment and accelerated domestic substitution, which have significantly lowered procurement costs for hospitals [6][7]. - The price of large imaging equipment like CT scanners has decreased by 40% over the past decade, with domestic equipment accounting for 50% of the market share in 2023 [6][7]. Group 4: Financial Implications - The annual costs for film and repeated examinations in resource-rich provinces could reach up to 50 billion yuan, potentially freeing up over 800 billion yuan annually if implemented nationwide [7]. - The new pricing rules focus on examination effectiveness rather than equipment parameters, promoting a more rational pricing structure based on clinical value [7]. Group 5: Future Outlook - The adjustments aim to balance patient costs and service efficiency, encouraging hospitals to improve operational efficiency in equipment use and service processes [7]. - Companies in the medical device sector will need to enhance service value and align with policies to sustain long-term growth amid pricing pressures [7].